Phenylethylamine for Health & Longevity - Quick Reference Sheet

Phenylethylamine for Health & Longevity

Created on 07/30/2026 – Quick Reference based on Evidence Review created using AI4L / Opus 4.8 Audit

A cheap, fast-acting molecule the body makes and food supplies, phenylethylamine briefly lifts mood, drive, and focus within minutes, then fades almost immediately. Evidence for lasting benefit is modest and unproven. Everyday doses seem well tolerated, but combining it with anything that blocks its breakdown can push blood pressure dangerously high; long-term safety is unknown. (Full Review)

Protocol

Dose
100–500 mg
Oral powder or capsule; start low (~100–250 mg)
Timing
15–30 min before
Earlier in the day; late dosing risks insomnia
Frequency
Acute, as-needed
Up to 500 mg two to three times daily cited
Time to effect
Onset
~15 min
Mood, energy, and focus lift felt quickly
Duration
30–60 min
Effects fade within about an hour
Half-life
Minutes
Rapid breakdown drives as-needed dosing

Benefits

Contraindications
  • Any MAO inhibitor (MAOI antidepressants, selegiline, moclobemide)
  • Uncontrolled hypertension (≥140/90 mmHg)
  • Cardiovascular disease, arrhythmia, or recent cardiac events
  • Bipolar or psychotic disorders
  • Anxiety or panic disorders
  • Pregnancy or breastfeeding
Key Interactions
  • MAO-inhibiting supplements (St. John's Wort, harmala/harmine, syrian rue)
  • Serotonergic & stimulant drugs (SSRIs, SNRIs, amphetamine, methylphenidate)
  • OTC sympathomimetics (pseudoephedrine, phenylephrine)
  • Additive stimulant supplements (caffeine, synephrine, hordenine, higenamine)

Risk & Side Effects

  • High:
  • Medium: Hypertensive reaction when combined with MAO inhibitors
  • Low: Stimulant-type effects; headache and migraine trigger
  • Speculative: Blood pressure and heart rate elevation at high doses; adverse psychiatric effects; unknown long-term safety

Monitoring

Marker Target Why
Blood pressure ~110–125 / 70–80 mmHg Detects pressor response and screens for pre-existing hypertension
Resting heart rate ~50–70 bpm Flags stimulant-driven increases in heart rate
Body weight / waist Stable to individual goal Relevant only if used for appetite or weight goals

Cadence: Baseline before first dose; recheck ~30–60 min after early doses, after the first week, then every few months

Qualitative Assessment

  • Mood and sense of well-being in the first hour after a dose
  • Focus, motivation, and mental energy, and how long they last
  • Sleep quality, especially with afternoon or evening dosing
  • Anxiety, jitteriness, or palpitations as early warning signs to reduce or stop